{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T08:23:19Z","timestamp":1791015799320,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","pediatr-neonatol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatrics & Neonatology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.pedneo.2024.10.005","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T22:36:01Z","timestamp":1730327761000},"page":"S13-S17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"S1","title":["Alport syndrome: Expanding diagnosis and treatment"],"prefix":"10.1016","volume":"66","author":[{"given":"Hou-Xuan","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Jung","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry A.","family":"Greenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pedneo.2024.10.005_bib1","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00467-020-04819-6","article-title":"Clinical practice recommendations for the diagnosis and management of Alport syndrome in children, adolescents, and young adults-an update for 2020","volume":"36","author":"Kashtan","year":"2021","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.pedneo.2024.10.005_bib2","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/ki.1994.413","article-title":"Immunohistochemical study of alpha 1-5 chains of type IV collagen in hereditary nephritis","volume":"46","author":"Nakanishi","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.pedneo.2024.10.005_bib3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1679\/aohc.70.255","article-title":"The distributions of type IV collagen alpha chains in basement membranes of human epidermis and skin appendages","volume":"70","author":"Hasegawa","year":"2007","journal-title":"Arch Histol Cytol"},{"key":"10.1016\/j.pedneo.2024.10.005_bib4","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2215\/CJN.10581014","article-title":"Ocular features in Alport syndrome: pathogenesis and clinical significance","volume":"10","author":"Savige","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.pedneo.2024.10.005_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/13816819709041431","article-title":"Alport syndrome. A review of the ocular manifestations","volume":"18","author":"Colville","year":"1997","journal-title":"Ophthalmic Genet"},{"key":"10.1016\/j.pedneo.2024.10.005_bib6","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1053\/j.ajkd.2009.06.023","article-title":"CKD in MYH9-related disorders","volume":"54","author":"Singh","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.pedneo.2024.10.005_bib7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJMoa1101273","article-title":"MYO1E mutations and childhood familial focal segmental glomerulosclerosis","volume":"365","author":"Mele","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pedneo.2024.10.005_bib8","doi-asserted-by":"crossref","DOI":"10.1172\/JCI147253","article-title":"Loss of the collagen IV modifier prolyl 3-hydroxylase 2 causes thin basement membrane nephropathy","volume":"132","author":"Aypek","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pedneo.2024.10.005_bib9","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1097\/01.ASN.0000090034.71205.74","article-title":"X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a \"European Community Alport Syndrome Concerted Action\" study","volume":"14","author":"Jais","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pedneo.2024.10.005_bib10","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1681\/ASN.V114649","article-title":"X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males","volume":"11","author":"Jais","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pedneo.2024.10.005_bib11","article-title":"Genotype-phenotype correlations for pathogenic COL4A3-COL4A5 variants in X-linked, autosomal recessive, and autosomal dominant Alport syndrome","volume":"9","author":"Savige","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.pedneo.2024.10.005_bib12","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1093\/ndt\/gfn681","article-title":"Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome","volume":"24","author":"Marcocci","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.pedneo.2024.10.005_bib13","article-title":"Clinical and genetic features of autosomal dominant Alport syndrome: a cohort study","volume":"78:560-570.e1","author":"Furlano","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.pedneo.2024.10.005_bib14","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1046\/j.1523-1755.2001.0590051670.x","article-title":"Segregation of hematuria in thin basement membrane disease with haplotypes at the loci for Alport syndrome","volume":"59","author":"Buzza","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.pedneo.2024.10.005_bib15","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1093\/ndt\/gfg157","article-title":"Novel COL4A4 splice defect and in-frame deletion in a large consanguine family as a genetic link between benign familial haematuria and autosomal Alport syndrome","volume":"18","author":"Gross","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.pedneo.2024.10.005_bib16","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1681\/ASN.2020071065","article-title":"Prevalence estimates of predicted pathogenic COL4A3-COL4A5 variants in a population sequencing database and their implications for Alport syndrome","volume":"32","author":"Gibson","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pedneo.2024.10.005_bib17","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/ki.2011.452","article-title":"Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations","volume":"81","author":"Temme","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.pedneo.2024.10.005_bib18","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1016\/j.ekir.2022.08.021","article-title":"A systematic review of pathogenic COL4A5 variants and proteinuria in women and girls with X-linked Alport syndrome","volume":"7","author":"Gibson","year":"2022","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.pedneo.2024.10.005_bib19","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.3390\/jcm11164883","article-title":"New insights into renal failure in a cohort of 317 patients with autosomal dominant forms of Alport syndrome: report of two novel heterozygous mutations in COL4A3","volume":"11","author":"Garc\u00eda-Aznar","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.pedneo.2024.10.005_bib20","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.ekir.2022.06.001","article-title":"Heterozygous pathogenic COL4A3 and COL4A4 variants (autosomal dominant Alport syndrome) are common, and not typically associated with end-stage kidney failure, hearing loss, or ocular abnormalities","volume":"7","author":"Savige","year":"2022","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.pedneo.2024.10.005_bib21","doi-asserted-by":"crossref","first-page":"8318","DOI":"10.1038\/s41467-023-43878-9","article-title":"Polygenic risk alters the penetrance of monogenic kidney disease","volume":"14","author":"Khan","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.pedneo.2024.10.005_bib22","doi-asserted-by":"crossref","first-page":"6827","DOI":"10.1038\/s41598-023-34053-7","article-title":"Genotype-phenotype correlation of X-linked Alport syndrome observed in both genders: a multicenter study in South Korea","volume":"13","author":"Kim","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.pedneo.2024.10.005_bib23","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1093\/ndt\/gfm024","article-title":"Alport syndrome and the X chromosome: implications of a diagnosis of Alport syndrome in females","volume":"22","author":"Kashtan","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.pedneo.2024.10.005_bib24","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.2215\/CJN.03120322","article-title":"Digenic Alport syndrome","volume":"17","author":"Savige","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.pedneo.2024.10.005_bib25","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/ndt\/gfv325","article-title":"Collagen (COL4A) mutations are the most frequent mutations underlying adult focal segmental glomerulosclerosis","volume":"31","author":"Gast","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.pedneo.2024.10.005_bib26","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/ki.2014.305","article-title":"Rare hereditary COL4A3\/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosis","volume":"86","author":"Malone","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.pedneo.2024.10.005_bib27","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJMoa1806891","article-title":"Diagnostic utility of exome sequencing for kidney disease","volume":"380","author":"Groopman","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pedneo.2024.10.005_bib28","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.ekir.2020.04.011","article-title":"Type IV collagen mutations in familial IgA nephropathy","volume":"5","author":"Li","year":"2020","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.pedneo.2024.10.005_bib29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0021-9975(97)80016-3","article-title":"Treatment of X-linked hereditary nephritis in Samoyed dogs with angiotensin converting enzyme (ACE) inhibitor","volume":"117","author":"Grodecki","year":"1997","journal-title":"J Comp Pathol"},{"key":"10.1016\/j.pedneo.2024.10.005_bib30","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1093\/ndt\/gfh219","article-title":"Antifibrotic, nephroprotective potential of ACE inhibitor vs AT1 antagonist in a murine model of renal fibrosis","volume":"19","author":"Gross","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.pedneo.2024.10.005_bib31","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/ki.2011.407","article-title":"Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy","volume":"81","author":"Gross","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.pedneo.2024.10.005_bib32","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.kint.2020.06.038","article-title":"Genotype-phenotype correlations influence the response to angiotensin-targeting drugs in Japanese patients with male X-linked Alport syndrome","volume":"98","author":"Yamamura","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.pedneo.2024.10.005_bib33","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00467-016-3452-z","article-title":"Prospective study on the potential of RAAS blockade to halt renal disease in Alport syndrome patients with heterozygous mutations","volume":"32","author":"Stock","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.pedneo.2024.10.005_bib34","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.kint.2019.12.015","article-title":"A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndrome","volume":"97","author":"Gross","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.pedneo.2024.10.005_bib35","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/MNH.0000000000000983","article-title":"Alport syndrome and Alport kidney diseases - elucidating the disease spectrum","volume":"33","author":"Puapatanakul","year":"2024","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.pedneo.2024.10.005_bib36","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.kint.2017.12.018","article-title":"Alport syndrome: a unified classification of genetic disorders of collagen IV \u03b1345: a position paper of the Alport Syndrome Classification Working Group","volume":"93","author":"Kashtan","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.pedneo.2024.10.005_bib37","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.ekir.2023.07.010","article-title":"The phenotypic spectrum of COL4A3 heterozygotes","volume":"8","author":"Solanki","year":"2023","journal-title":"Kidney Int Rep"}],"container-title":["Pediatrics & Neonatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957224001918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957224001918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T16:33:01Z","timestamp":1739809981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875957224001918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":37,"alternative-id":["S1875957224001918"],"URL":"https:\/\/doi.org\/10.1016\/j.pedneo.2024.10.005","relation":{},"ISSN":["1875-9572"],"issn-type":[{"value":"1875-9572","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alport syndrome: Expanding diagnosis and treatment","name":"articletitle","label":"Article Title"},{"value":"Pediatrics & Neonatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pedneo.2024.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2025, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}